naltrexone has been researched along with 3-acetyl-6-deoxy-6-fluoronaltrexone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasberg, RG; Channing, M; Dunn, B; Kawai, R; Newman, AH; Rice, KC; Sawada, Y | 1 |
| Blasberg, RG; Hiraga, S; Ito, K; Patlak, CS; Pettigrew, KD; Sawada, Y | 1 |
| Blasberg, RG; Channing, M; Kawai, R; Newman, AH; Rice, KC; Sawada, Y | 1 |
| Aulakh, CS; Benkelfat, C; Bykov, V; De Costa, BR; Rice, KC; Rothman, RB | 1 |
| Lessor, R; McLean, S; Rice, KC; Rothman, RB | 1 |
| Bykov, V; Holaday, JW; Jacobson, AE; Lessor, RA; McLean, S; Rice, KC; Rothman, RB | 1 |
| Bykov, V; De Costa, BR; Jacobson, AE; Newman, AH; Reid, A; Rice, KC; Rothman, RB | 1 |
| Burke, T; Carson, R; Channing, M; Cohen, R; Dunn, B; Finn, R; Larson, S; Newman, A; Ostrowski, N; Simpson, N | 1 |
| McLean, S; Rothman, RB | 1 |
| Bennett, JM; Burke, TR; Channing, MA; Eckelman, WC; Rice, KC | 1 |
| Burke, TR; Ostrowski, NL; Pert, A; Pert, CB; Rice, KC | 1 |
| Bennett, JM; Burke, TR; Channing, MA; Danks, JA; Eckelman, WC; Larson, SM; Pert, CB; Rice, KC | 1 |
1 review(s) available for naltrexone and 3-acetyl-6-deoxy-6-fluoronaltrexone
| Article | Year |
|---|---|
Ligands for imaging opioid receptors in conscious humans by positron emission tomography (PET).
Topics: Animals; Brain; Humans; Naltrexone; Radioligand Assay; Receptors, Opioid; Tomography, Emission-Computed | 1988 |
11 other study(ies) available for naltrexone and 3-acetyl-6-deoxy-6-fluoronaltrexone
| Article | Year |
|---|---|
Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
Topics: Animals; Biological Transport; Brain; Fluorine Radioisotopes; Male; Models, Biological; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Receptors, Opioid; Stereoisomerism; Tritium | 1990 |
Cerebrovascular transport of [125I]quinuclidinyl benzilate, [3H]cyclofoxy, and [14C]iodoantipyrine.
Topics: Animals; Antipyrine; Biological Transport; Blood Proteins; Capillaries; Carbon Radioisotopes; Cerebrovascular Circulation; Diffusion; Erythrocytes; Indicator Dilution Techniques; Iodine Radioisotopes; Male; Models, Cardiovascular; Naltrexone; Permeability; Quinuclidines; Quinuclidinyl Benzilate; Rats; Time Factors; Tritium | 1990 |
BBB transport and rapid tissue binding of cyclofoxy: comparison of active and inactive enantiomers.
Topics: Animals; Antipyrine; Binding, Competitive; Biological Transport; Blood-Brain Barrier; Cerebrovascular Circulation; Hydrogen-Ion Concentration; Kinetics; Lipid Metabolism; Male; Naltrexone; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramine.
Topics: Animals; Brain Chemistry; Clomipramine; Down-Regulation; Kinetics; Male; Naltrexone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1989 |
[3H]cyclofoxy, a ligand suitable for positron emission tomography, labels mu and kappa opioid receptors.
Topics: Animals; Autoradiography; Brain Chemistry; Guinea Pigs; Male; Naltrexone; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tomography, Emission-Computed | 1987 |
Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography.
Topics: Alkylating Agents; Animals; Binding, Competitive; Drug Tolerance; Enkephalin, Leucine; In Vitro Techniques; Male; Morphine; Naloxone; Naltrexone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Tomography, Emission-Computed | 1987 |
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro.
Topics: Animals; Binding, Competitive; Brain; Guinea Pigs; Isomerism; Kinetics; Membranes; Naltrexone; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 1988 |
An examination of the opiate receptor subtypes labeled by [3H]cycloFOXY: an opiate antagonist suitable for positron emission tomography.
Topics: Animals; Autoradiography; Brain; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Naloxone; Naltrexone; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Synaptic Membranes; Tomography, Emission-Computed | 1988 |
Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonist.
Topics: Animals; Chromatography, High Pressure Liquid; Fluorine; Indicators and Reagents; Isotope Labeling; Kinetics; Naloxone; Naltrexone; Narcotic Antagonists; Radioisotopes; Receptors, Opioid | 1985 |
The pattern of [3H]cyclofoxy retention in rat brain after in vivo injection corresponds to the in vitro opiate receptor distribution.
Topics: Animals; Autoradiography; Brain; Cerebellum; Densitometry; Image Processing, Computer-Assisted; Injections; Male; Naloxone; Naltrexone; Rats; Rats, Inbred Strains; Receptors, Opioid; Tissue Distribution; Tritium | 1987 |
3-[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animals.
Topics: Animals; Autoradiography; Binding, Competitive; Brain; Cell Membrane; Fluorine; Naloxone; Naltrexone; Radioisotopes; Rats; Receptors, Opioid; Tissue Distribution | 1984 |